You searched for "pharmaceutical"
Mind the gap – developing a sustainable pipeline for hearing therapeutics
In this article, the authors describe three key challenges faced in developing hearing therapeutics. Collaboration between companies, sectors and disciplines will be key to finding solutions. The unmet need for therapies for hearing loss grows apace, with prevalence rising across...
Pharmacological treatment of glue ear in children
Otitis media with effusion (OME), also known as glue ear, is a common cause of hearing loss in children. Most cases resolve spontaneously within three months. Early and proper management of OME can help avoid hearing and speech impairment that...
Do certain chronic medications increase dysphagia in older people?
Oropharyngeal dysphagia is known to affect a high number of older people in the community, in care homes and in acute geriatric admissions to hospital. The authors of this study have recognised that many older people take drugs for chronic...
Role of potassium channel opener in salicylate induced tinnitus
The exact mechanism in the origin of tinnitus is not known. Many pharmacological agents have been tried to to treat tinnitus without great success. Aspirin is a commonly used medicine in the elderly population to reduce the risk of stroke...Developing outcome measures for research
There are challenges in developing outcomes measures; Professor Hall presents five top pointers for making rapid progress in developing outcome measures for research purposes. Anyone who has worked clinically with hearing loss will appreciate that every patient’s experience is personal....Genomic testing for deafness and its implications
Gene therapies for hearing loss are rapidly advancing and will be transitioning to clinical practice. Here, the authors explain why clinicians involved in managing these disorders need to be aware of these advances. Genomic testing in England was significantly reconfigured...Will it ever happen?
Audiology is a rapidly evolving field, with many exciting developments on the horizon. David Baguley identified some topics of interest, and asked some international experts ‘will it ever happen?’ Gene therapy for deafness After years of development, gene therapy for...Pre-clinical development of magnetic delivery of therapy to middle and inner ears
Why are we developing this technology? A key problem in drug delivery is getting the therapy to the right place in the body, which is especially challenging for targets that are small, deep and are protected or surrounded by anatomical...In conversation with Prof Peter Friedland – Reflections on an extraordinary career and life
Our illustrious friend, Harvey Coates, hears about Professor Friedland’s amazing personal journey, ranging from horrifying exposure to violence through to his clinical care for (and friendship with) Nelson Mandela and his prevailing passion for teaching. Professor Peter Friedland. Professor Peter...Sialendoscopy
Recent advances in endoscopic technology allow the ENT surgeon to access the salivary gland ductal system for both diagnostic and therapeutic reasons. In this article the authors share their experiences with using this technology, both as a standalone procedure and...Aligning hearing and cognitive healthcare in older people
Published in print under the titleHearing care and dementia: professional insights on the new Lancet Commission findingsThe Lancet Commission on ‘Dementia prevention, intervention and care: 2024 report’ highlights a list of potential modifiable factors to reduce dementia risk. As with...
